Australia
Bonnell Electric Unleashes the 775 Series: The Future of Electric Performance is Here
AUSTIN, Texas, April 1, 2025 /PRNewswire/ -- Bonnell Electric is shaking up the e-MTB and e-moto landscape with the official launch of the 775 series. A revolutionary blend of power, precision, and adaptability, the 775 lineup is designed to push boundaries, offering three distinct ways to ride—w...
2025-04-01 23:30
3987
Seeing Machines Announces 3D Camera Technology for Next-Generation In-Cabin Monitoring Systems
* Seeing Machines and Airy3D partner to supply the Automotive industry with low-impact, trustworthy 3D-vision for future in-cabin systems. CANBERRA, Australia, April 1, 2025 /PRNewswire/ -- Seeing Machines, the advanced computer vision technology company that designs AI-powered operator monitor...
2025-04-01 22:20
3007
Canadian Solar and Flow Power to Install Innovative Anti-Hail Solar Panels
Canadian Solar's new anti-hail technology is set to be installed at a new South
Australian solar BESS energy project by Flow Power, enhancing the resilience of
solar energy inAustralia's harsh climate.
KITCHENER, ON, April 1, 2025 /PRNewswire/ -- Canadian Solar Inc.
2025-04-01 19:00
2862
ECHO IQ SIGNS STRATEGIC PARTNERSHIP AND INTEGRATION AGREEMENTS WITH SCIMAGE AND MEDAXIOM TO EXPAND ECHOSOLV AS ACROSS 36 US CARDIOLOGY NETWORKS
* EchoSolv AS will be fully integrated into ScImage's medical workflow platform, facilitating streamlined deployment within MedAxiom's hospital and cardiology networks. * ScImage is a nationally recognised Cloud and integrated workflow management platform, with over 1,200 users, specialisin...
2025-04-01 13:39
2909
NEURIM PHARMACEUTICALS RECEIVES EUROPEAN MARKETING AUTHORIZATION FOR PEDIATRIC PROLONGED-RELEASE MELATONIN (SLENYTO®) FOR THE TREATMENT OF INSOMNIA IN CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
TEL AVIV, Israel, March 26, 2025 /PRNewswire/ -- Neurim Pharmaceuticals
2025-03-26 17:00
3443
Ractigen's RAG-01 Shows Promising Early Complete Responses in Phase I NMIBC Trial, Data Presented at EAU 2025
NANTONG, China and MELBOURNE, Australia, March 24, 2025 /PRNewswire/ -- Ractigen Therapeutics, a clinical-stage biopharmaceutical company pioneering small activating RNA (saRNA) therapeutics, today announced the presentation of positive preliminary data from its ongoing Phase I clinical trial of ...
2025-03-24 20:30
3551
Seeing Machines announces new technology and safety appointments
CANBERRA, Australia, March 24, 2025 /PRNewswire/ -- Seeing Machines Limited (AIM: SEE, "Seeing Machines" or the "Company"), the advanced computer vision technology company that designs AI-powered operator monitoring systems to improve transport safety, is pleased to announce the appointment ofJoh...
2025-03-24 15:00
2379
GCF Global Research Amplifies Movie-Goers' Voices: They Want More
Nothing Stands in the Way of a Cinema Visit When the Right Movie is Playing SYDNEY, March 19, 2025 /PRNewswire/ -- The Global Cinema Federation (GCF), representing global cinema exhibition, is excited to announce the results of its latest global customer research, highlighting the voices of consu...
2025-03-20 02:00
2281
CStone Submits Clinical Trial Application in Australia for CS5001 (ROR1 ADC) in Combination with First-Line Standard-of-Care for DLBCL
* Phase Ib trial to evaluate CS5001 in combination with R-CHOP as a first-line treatment for diffuse large B-cell lymphoma (DLBCL), aiming to reshape the standard-of-care landscape. * CS5001 is also being investigated globally in a multi-center Phase Ib clinical trial for multiple solid tumor...
2025-03-06 08:10
2585
SECuRE trial update: 92% of pre-chemo participants experience greater than 35% drop in PSA levels across all cohorts. Cohort Expansion Phase commences.
HIGHLIGHTS * Safety Review Committee (SRC) meeting confirms end of the Dose Escalation Phase and commencement of the Cohort Expansion Phase (Phase II stage) of the SECuRE study. * Based on the efficacy and safety assessment of all cohorts and the focus on earlier stages of treatment, the SRC...
2025-03-05 21:44
2948
Seeing Machines names Mitsubishi Electric Automotive America as a referral partner to drive accelerated sales of Guardian Generation 3 in The Americas
CANBERRA, Australia, Feb. 24, 2025 /PRNewswire/ -- Seeing Machines Limited (AIM: SEE), the advanced computer vision technology company that designs AI-powered operator monitoring systems to improve transport safety, announces that Mitsubishi Electric Automotive America, Inc. ("MEAA") has signed a...
2025-02-24 20:00
3000
FIRST AND ONLY TREATMENT FOR CHRONIC HYPOPARATHYROIDISM APPROVED IN AUSTRALIA
* YORVIPATH® (palopegteriparatide) is now registered by the Therapeutic Goods Administration (TGA) for the treatment of chronic hypoparathyroidism in adults1 * First-in-class novel PTH replacement therapy * Australia becomes the first country to obtain Marketing Authorisation for YORVIPATH s...
2025-02-21 00:01
3011
Silicon Quantum Computing achieves world-leading accuracy of Grover's algorithm without error correction
SYDNEY, Feb. 20, 2025 /PRNewswire/ -- Silicon Quantum Computing (SQC), a pioneer in quantum computing and atomic manufacturing, today announced that it has demonstrated world-leading accuracy in the operation of Grover's algorithm without error correction, i.e. in its native pure form. This prove...
2025-02-20 18:10
2647
Clarity receives US FDA Fast Track Designation for the treatment of metastatic castration-resistant prostate cancer patients with Cu-67 SAR-bisPSMA
SYDNEY, Feb. 19, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce thatthe Un...
2025-02-19 22:09
3045
ClassDojo CTO backs kid-tech gaming app, Polymath in $1M raise
AUCKLAND, New Zealand, Feb. 17, 2025 /PRNewswire/ -- Kid-tech startup Polymath has secured$1M USD in funding with notable investment from ClassDojo CTO Liam Don in their first angel round, followed by a venture-backed pre-seed raise co-led by Blackbird Ventures and GD1. This investment accelerate...
2025-02-18 02:30
2760
An independent third-party performance assessment confirms that the Aquarius AQ 150 engine demonstrates 25% higher efficiency than the world's leading engines, operates on multiple fuel types, and is significantly lighter than existing alternatives
As a reminder, Aquarius' innovative systems generate and supply clean electricity, designed to enable ultra-fast charging for electric vehicles in the rapidly growing EV market. Aquarius' systems are smaller and more efficient than existing market solutions and do not depend on the power grid. A...
2025-02-14 06:00
7048
Nuix Awarded Patent for Breakthrough Deep Learning Technology for Training AI
SYDNEY, Feb. 10, 2025 /PRNewswire/ -- Nuix Ltd. (ASX: NXL), a global leader in data processing, investigative analytics and intelligent software, has today announced it has been granted a patent for pioneering a novel technology system that uses advanced deep learning techniques to better train a...
2025-02-11 11:35
2246
Canadian Solar's e-STORAGE to Deliver 960 MWh of Energy Storage Systems for Copenhagen Infrastructure Partners in Australia
KITCHENER, ON, Feb. 10, 2025 /PRNewswire/ -- Canadian Solar Inc
2025-02-10 20:00
3508
Argent BioPharma: A Hidden Gem traded Under $12M--Edison Group Report Assigned a $327M Valuation to Its Breakthrough Epilepsy Treatment
PERTH, Australia, Feb. 6, 2025 /PRNewswire/ -- Argent BioPharma (ASX: RGT) (OTCQB: RGTLF), a clinical-stage biopharmaceutical company brings hope to epilepsy patients. For thousands of patients with refractory epilepsy—commonly referred to as drug-resistant epilepsy—the search for effective trea...
2025-02-06 05:00
2720
Actinogen announces new and unique nonproprietary name of 'emestedastat' for Xanamem
Late-stage Alzheimer's trial opens 10 new sites in USA, with results due in 2025 and 2026 SYDNEY, Feb. 5, 2025 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) announces that the World Health Organization (WHO) has granted the nonproprietary name of 'emestedastat' to Actinogen for its Xaname...
2025-02-05 22:18
3154
Week's Top Stories
Most Reposted
Agoda Establishes Strategic Partnership with Taipei City Government, Promoting International Tourism Development
[Picked up by 312 media titles]
2026-04-16 17:15
Hai Robotics and Maersk Redefine Fashion Fulfilment with High-Density Robotics at 10-Metre Scale in Singapore
[Picked up by 298 media titles]
2026-04-14 10:00
Blaize and Winmate Announce Strategic Collaboration to Advance Sovereign Edge AI Capabilities for Defense and Critical Infrastructure
[Picked up by 296 media titles]
2026-04-16 18:00
One Bangkok Hosted "Sunsational Songkran Festival 2026"
[Picked up by 289 media titles]
2026-04-16 15:34
Silicon Box Announces It Joins Imec Automotive Chiplet Program to Strengthen Chip Supply Chains for Next-Generation Vehicles
[Picked up by 288 media titles]
2026-04-15 21:02
Most Read
Blaize Announces Expected First Quarter 2026 Revenue and Newly Awarded Contract with NeoTensr Anticipated to Generate $50.0 Million in Revenue
2026-04-14 21:43
5914
NYSE Content Update: U.S.-Based Diversified Energy to Ring Bell for 25 Years Since its Founding
2026-04-13 21:06
5439
Makerfire Adopts Breakthrough USX51 Industrial-Grade AI Flight Controller: Empowering Enterprises to Cut Costs and Boost Efficiency in Low-Altitude Operations
2026-04-11 01:00
5359
OCI Global Publishes 2025 Annual Report and Audited Financial Statements
2026-04-11 00:49
4850